INTERPACE BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Interpace Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Interpace Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $9K, a 83% decline year-over-year.
  • Interpace Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $183K, a 55.7% decline year-over-year.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $291K, a 53.8% decline from 2023.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $630K, a 47.1% decline from 2022.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.19M, a 15.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $291K -$339K -53.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $630K -$561K -47.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $1.19M +$159K +15.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.03M -$1.16M -52.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $2.19M +$652K +42.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $1.54M -$199K -11.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-01
2018 $1.73M +$674K +63.6% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
2017 $1.06M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.